Every Monday we synthesize CDC disease surveillance, nationwide patient search trends, and state-level chronic disease prevalence into a single briefing. Built for operators who plan capacity and ad spend on real demand, not lagging indicators.
Wikipedia traffic for Zepbound jumped 47% WoW as thyroid, sciatica, and PCOS interest all climbed double digits.
Pulmonology demand signal jumps 140% on Wikipedia while Wegovy scores a fresh FDA nod and COVID rises in Texas.
A back-pain spike leads the EDI while depression and anxiety pipelines quietly expand — respiratory stays quiet outside a Texas COVID uptick.
Menopause searches spike while orthopedic intent fades into summer — operators should shift capacity now.
Mental health and menopause searches surge in the background while celebrity-driven Ozempic chatter dominates breakout queries.
Wikipedia traffic for weight-loss drugs jumps double digits across the board while a thyroid signal quietly emerges.
Wikipedia pageviews for perimenopause jumped 32% WoW, leading an EDI board still dominated by GLP-1s.
Mental health and fertility search behavior are diverging from the rest of the demand curve — operators should take note.
An 80% pageview surge and 7 new trials push endometriosis to the top of the EDI; GLP-1 chatter stays hot.
Wikipedia attention is doing the heavy lifting this week as COVID search falls 19% and respiratory signals normalize.
Wikipedia traffic for Zepbound and Mounjaro jumps ~37% WoW, while Long COVID interest spikes 49% on stale CDC content.
Weight-loss demand reaccelerates on a fresh FDA action while fertility chatter spikes 130% on Reddit.
Weight-loss drug curiosity is splintering — from celebrity gossip to discontinuation fears — while AFib sends a split signal.
Annual physicals and joint replacements drive April demand while COVID searches hit 90-day lows.